Skip to content
Screener

Archer Aviation ACHR Business Segments — Research and development warrant expense

Similar metrics at other companies

Avalo Therapeutics logo
AVTXReportable Segment — Research and development expense
$23.42M+66.4%
Guardant Health logo
GHReportable Segment — Research and development expense
$76.59M+2.3%
Viridian Therapeutics, Inc. logo
VRDNReportable Segment — Segment research and development expense
$64.19M-21.1%
Momentus logo
MNTSReportable Segment — Research and development expenses
$4.17M+118%
Powell Industries logo
POWLReportable Segment — Research and development expenses
$4.29M+56.2%
Eos Energy Enterprises, Inc. logo
EOSEReportable Segment — Research and development expenses
$10.51M+45.9%

Other financials

Income statement

See full
Revenue$1.6M
Gross profit$300.0K
Operating income-$254.6M-76.8%
Net income-$217.7M-133%
EPS (diluted)-$0.28-64.7%

Balance sheet

See full
Cash & equivalents$958.4M-7.6%
Total debt$121.8M+55.6%
Total equity$2.1B+106%
Total assets$2.3B+91.2%

Cash flow

See full
Operating cash flow-$149.1M-57.6%
CapEx$32.6M+226%
Free cash flow-$181.7M-73.7%

Valuation

See full
Market cap$3.99B-26.2%
Enterprise value$3.15B-16.3%
P/S2,493.6×

Profitability

See full
Gross margin18.8%
Operating margin-52,493.8%
Net margin-46,406.3%
FCF margin-36,800%

Returns & leverage

See full
Return on equity-48%-12.4pp
Debt / equity0.1×0.0×
Current ratio18.1×+2.3×

Where this comes from

Reported directly by Archer Aviation in its filing.

Tagged under the XBRL concept achr:ResearchAndDevelopmentWarrantExpense.

The source filing: Archer Aviation’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 5:01 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001824502-26-000038
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Revenue$1.6
Operating expenses
Depreciation and amortization expense7.84.1
Research and development warrant expense0.8
Stock-based compensation expense70.430.1
General and administrative warrant expense1.1
Other cost of revenue0.9
Other research and development expense133.388.2

Item 1. Financial Statementsii

FAQ

What is Archer Aviation's business segments — research and development warrant expense?
Archer Aviation (ACHR) reported business segments — research and development warrant expense of $0 in Q1 2026.
What does business segments — research and development warrant expense mean?
This captures the non-cash accounting expense associated with warrants issued to partners or vendors specifically related to research and development activities. It reflects the cost of incentivizing external collaboration to accelerate technological innovation.

Ask your AI about Archer Aviation's business segments — research and development warrant expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude